JP Morgan Maintains Overweight on Repligen, Raises Price Target to $200
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Rachel Vatnsdal maintains an Overweight rating on Repligen (NASDAQ:RGEN) and raises the price target from $190 to $200.
July 31, 2024 | 6:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Rachel Vatnsdal maintains an Overweight rating on Repligen and raises the price target from $190 to $200.
The Overweight rating and increased price target from a reputable analyst at JP Morgan is likely to boost investor confidence in Repligen, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100